Caplin Point Laboratories
CAPLIPOINT
Pharma₹2612.00
price as of 3/10/2026, 12:12:58 am
Market cap ₹19,854 Cr
- P/E
- 29.89
- Day range
- ₹2,540.00 – ₹2,719.90
- 52-week range
- ₹1,500.30 – ₹2,990.00
- Volume
- 1.54 L
- Open
- ₹2,710.00
- Prev close
- ₹2,716.40
No red flags in exchange filings: no rising pledge, promoter selling, surveillance or critical filing on record.
CAPLIPOINT in NSE indices and F&O
Research profile
Derived metrics
- Earn. yield
- 3.3%
Percentiles rank this stock against the other tracked stocks and change as they do. Scans describe where figures sit today. Hover a label for its definition. Not investment advice.
Peer comparison
All 44 in Pharma| Company | M-cap | P/E | P/B | ROE | ROCE | OPM | D/E | Sales YoY |
|---|---|---|---|---|---|---|---|---|
| Sun PharmaSUNPHARMA | ₹432.1K Cr | 35.71 | 5.18 | 14.8% | 21.0% | 29.0% | 0.06 | +10.5% |
| Divi's LaboratoriesDIVISLAB | ₹245.5K Cr | 83.82 | 14.66 | 16.2% | 22.0% | 41.0% | 0.00 | +27.8% |
| Torrent PharmaTORNTPHARM | ₹181.3K Cr | 76.11 | 19.22 | 26.8% | 15.0% | 34.0% | 1.79 | +54.8% |
| Apollo HospitalsAPOLLOHOSP | ₹116.9K Cr | 56.14 | 13.60 | 22.6% | 17.0% | 16.0% | 0.90 | +20.6% |
| Zydus LifesciencesZYDUSLIFE | ₹114.3K Cr | 25.57 | 4.26 | 20.1% | 21.0% | 24.0% | 0.46 | +22.0% |
| CiplaCIPLA | ₹108.6K Cr | 32.26 | 3.20 | 11.8% | 15.0% | 17.0% | 0.02 | +2.3% |
| Laurus LabsLAURUSLABS | ₹107.2K Cr | 98.02 | 20.20 | 18.2% | 18.0% | 32.0% | 0.48 | +29.0% |
| Caplin Point LaboratoriesCAPLIPOINT | ₹19.9K Cr | 29.89 | — | — | — | — | — | — |
| Sector median | ₹45.8K Cr | 49.95 | 5.80 | 14.6% | 16.0% | 22.5% | 0.31 | +17.1% |
Sector as classified in the tracked universe; medians use every tracked Pharma company, and P/E only profitable ones. Tinted figures beat the median.
Financials not yet synced
This company is tracked, but its filings have not been processed yet. Results appear here once the next sync reaches it.
Corporate actions
No dividends, splits or bonuses recorded for this company yet.
FAQ
Caplin Point Laboratories: common questions
Answered from the figures on this page.
Caplin Point Laboratories last traded at ₹2,612.00 (NSE, as of 3 Oct 2026). The last session moved it down 3.84%.
Caplin Point Laboratories is valued at about ₹19,854 crore (NSE, as of 3 Oct 2026).
Caplin Point Laboratories trades at a price-to-earnings ratio of 29.89 (NSE, as of 3 Oct 2026). The P/E compares the share price with earnings per share, so it is only comparable between companies in the same industry.
Caplin Point Laboratories has traded between ₹1,500.30 and ₹2,990.00 over the past 52 weeks, to 3 Oct 2026. It is currently 75% of the way up that range.
Caplin Point Laboratories (CAPLIPOINT) is classified under Pharma on this site's screener.
